5/29
04:05 pm
crdf
Cardiff Oncology to Present at the Jefferies Healthcare Conference
Low
Report
Cardiff Oncology to Present at the Jefferies Healthcare Conference
5/21
11:42 pm
crdf
Cardiff Oncology's Onvansertib: A Speculative Buy With Promising Data [Seeking Alpha]
Medium
Report
Cardiff Oncology's Onvansertib: A Speculative Buy With Promising Data [Seeking Alpha]
5/13
04:05 pm
crdf
Cardiff Oncology to Present at Upcoming Investor Conferences in May
Low
Report
Cardiff Oncology to Present at Upcoming Investor Conferences in May
5/6
08:06 am
crdf
Cardiff Oncology, Inc. (NASDAQ: CRDF) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
Low
Report
Cardiff Oncology, Inc. (NASDAQ: CRDF) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
5/4
08:57 am
crdf
Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
5/3
11:23 am
crdf
Cardiff Oncology, Inc. (NASDAQ:CRDF) Q1 2023 Earnings Call Transcript [Yahoo! Finance]
High
Report
Cardiff Oncology, Inc. (NASDAQ:CRDF) Q1 2023 Earnings Call Transcript [Yahoo! Finance]
5/2
04:13 pm
crdf
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update [Yahoo! Finance]
High
Report
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update [Yahoo! Finance]
5/2
04:05 pm
crdf
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
High
Report
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
4/29
06:58 am
crdf
Global PLK Targeted Therapies Market Opportunity & Clinical Trials Insight 2024 - Groundbreaking Advances in PLK Targeted Therapies Promise to Revolutionize Treatment for Cancer and Other Diseases [Yahoo! Finance]
Medium
Report
Global PLK Targeted Therapies Market Opportunity & Clinical Trials Insight 2024 - Groundbreaking Advances in PLK Targeted Therapies Promise to Revolutionize Treatment for Cancer and Other Diseases [Yahoo! Finance]
4/25
04:05 pm
crdf
Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
Low
Report
Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
4/8
04:11 pm
crdf
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study [Yahoo! Finance]
Low
Report
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study [Yahoo! Finance]
4/8
04:05 pm
crdf
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
Low
Report
Cardiff Oncology Presents Novel Preclinical Data at AACR Annual Meeting 2024 that Supports Ongoing First-line RAS-mutated mCRC Clinical Study
4/1
10:37 am
crdf
Cardiff Oncology (CRDF) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
Medium
Report
Cardiff Oncology (CRDF) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]